Yield10 Bioscience, Inc. (YTEN)
OTCMKTS: YTEN · Delayed Price · USD
1.020
-0.110 (-9.73%)
Jul 2, 2024, 3:08 PM EDT - Market closed
Yield10 Bioscience Revenue
Yield10 Bioscience had revenue of $360.00K in the twelve months ending March 31, 2024, down -0.28% year-over-year. Revenue in the quarter ending March 31, 2024 was $300.00K with 400.00% year-over-year growth. In the year 2023, Yield10 Bioscience had annual revenue of $60.00K, a decrease of -86.67%.
Revenue (ttm)
$360.00K
Revenue Growth
-0.28%
P/S Ratio
1.82
Revenue / Employee
$12,414
Employees
29
Market Cap
655.40K USD
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 60.00K | -390.00K | -86.67% |
Dec 31, 2022 | 450.00K | -164.00K | -26.71% |
Dec 31, 2021 | 614.00K | -185.00K | -23.15% |
Dec 31, 2020 | 799.00K | -7.00K | -0.87% |
Dec 31, 2019 | 806.00K | 250.00K | 44.96% |
Dec 31, 2018 | 556.00K | -388.00K | -41.10% |
Dec 31, 2017 | 944.00K | -215.00K | -18.55% |
Dec 31, 2016 | 1.16M | -1.44M | -55.32% |
Dec 31, 2015 | 2.59M | -206.00K | -7.36% |
Dec 31, 2014 | 2.80M | -2.59M | -48.09% |
Dec 31, 2013 | 5.39M | -36.92M | -87.25% |
Dec 31, 2012 | 42.32M | 40.89M | 2,869.54% |
Dec 31, 2011 | 1.43M | 977.00K | 218.08% |
Dec 31, 2010 | 448.00K | -977.00K | -68.56% |
Dec 31, 2009 | 1.43M | -130.00K | -8.36% |
Dec 31, 2008 | 1.56M | -128.00K | -7.61% |
Dec 31, 2007 | 1.68M | -2.91M | -63.33% |
Dec 31, 2006 | 4.59M | 1.81M | 65.05% |
Dec 31, 2005 | 2.78M | -897.20K | -24.39% |
Dec 31, 2004 | 3.68M | 1.29M | 54.34% |
Dec 31, 2003 | 2.38M | 394.23K | 19.82% |
Dec 31, 2002 | 1.99M | - | - |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
BHP Group | 55.34B |
Rio Tinto Group | 54.04B |
Vale S.A. | 41.78B |
Linde | 32.76B |
Freeport-McMoRan | 23.79B |
The Sherwin-Williams Company | 22.98B |
Ecolab | 15.50B |
Newmont | 13.16B |
YTEN News
- 15 days ago - Rothamsted Research Grants Yield10 Bioscience an Exclusive, Global Commercial License to Advanced Technology for Producing Omega-3 Products in Camelina - GlobeNewsWire
- 5 weeks ago - Yield10 Bioscience Announces Addition of Camelina to INTERLINE® Herbicide Label - GlobeNewsWire
- 6 weeks ago - Yield10 Bioscience Announces First Quarter 2024 Financial Results - GlobeNewsWire
- 6 weeks ago - Yield10 Bioscience Announces Delisting from Nasdaq - GlobeNewsWire
- 2 months ago - Yield10 Bioscience Announces 1-for-24 Reverse Stock Split - GlobeNewsWire
- 3 months ago - Yield10 Bioscience Announces Fourth Quarter and Full Year 2023 Financial Results - GlobeNewsWire
- 3 months ago - Yield10 Bioscience to Announce Fourth Quarter and Full Year 2023 Financial Results and Host a Conference Call on Monday, April 1, 2024 - GlobeNewsWire
- 3 months ago - Yield10 Bioscience Announces that the Plant Biosafety Office of the Canadian Food Inspection Agency has Cleared Genome-edited E3902 Camelina for Planting in Canada - GlobeNewsWire